| Bradley S Nydegger, DDS | |
|
Highway 162 & Biggar Lane, Covelo, CA 95428-0247 | |
| (707) 983-6404 | |
| (707) 983-6184 |
| Full Name | Bradley S Nydegger |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | Highway 162 & Biggar Lane, Covelo, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396967782 | NPI | - | NPPES |
| 1066 | Other | CA | PIN # |
| 36970 | Other | CA | LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 36970 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bradley S Nydegger, DDS Po Box 247, Covelo, CA 95428-0247 Ph: (707) 983-6404 | Bradley S Nydegger, DDS Highway 162 & Biggar Lane, Covelo, CA 95428-0247 Ph: (707) 983-6404 |
News Archive
Duke University researchers have taken a major step towards realizing a new form of MRI that could record biochemical reactions in the body as they happen.
Kaiser Health News writer Christopher Weaver, in a story produced in collaboration with the Los Angeles Times, looks at the government's plan to close the Medicare prescription drug "doughnut hole."
Like it or not, as we age, our muscle cells are slowly exchanged, one by one, for fat cells. This process quickens when we injure a muscle, and an extreme form of this process is also seen in muscle-wasting diseases such as Duchenne muscular dystrophy (DMD).
One in eight children living with HIV/AIDS "experiences triple-class virological failure - meaning the virus becomes resistant to multiple drugs - within five years of starting antiretroviral treatment," according to a study published Wednesday in the Lancet, HealthDay News/MSN reports. The "failure rate is higher than in adults and highlights the challenge of maintaining viral load suppression in young patients who begin antiretroviral therapy so early in life, the researchers said," according to the news service (Preidt, 4/19).
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 5 days ago
Someth Lor, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: Highway 162 & Biggar Lane, Covelo, CA 95428 Phone: 707-983-6404 Fax: 707-983-6184 | |
Dr. Craig B Emerson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Highway 162 And Biggar Lane, Covelo, CA 95428 Phone: 707-983-6404 Fax: 707-983-6051 |